ARHGDIB Monoklonaler Antikörper

ARHGDIB Monoklonal Antikörper für WB, IHC, IF-P, Indirect ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IHC, IF-P, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3E7B7

Kat-Nr. : 66054-1-PBS

Synonyme

3E7B7, GDIA2, GDID4, Ly GDI, Ly-GDI



Geprüfte Anwendungen

Produktinformation

66054-1-PBS bindet in WB, IHC, IF-P, Indirect ELISA ARHGDIB und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen ARHGDIB fusion protein Ag9091
Vollständiger Name Rho GDP dissociation inhibitor (GDI) beta
Berechnetes Molekulargewicht 201 aa, 23 kDa
Beobachtetes Molekulargewicht 27 kDa
GenBank-ZugangsnummerBC009200
Gene symbol ARHGDIB
Gene ID (NCBI) 397
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ARHGDIB, also known as RhoGDI2, is a conserved member of the RhoGDI family and plays an important role in cell migrations. It regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. It is mainly in hematopoietic, endothelial, and epithelial cells. It has been linked to tumorigenesis and metastasis. RhoGDI2 expression is downregulated in several cancer types, such as bladder, lung and lymphoma, but is upregulated in prostate and gastric cancer.